Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Two-year rates of death or urgent transplantation in statin versus no-statin cohorts. The benefit associated with statin therapy in the total cohort was compared with subgroups of men and women, those with cholesterol above and below the median level (163 mg/dl), and a subgroup excluding patients who underwent elective or urgent transplantation. HR = hazard ratio with statin therapy (Rx); TC = total cholesterol.
|
